Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.


FDA delays review of Novartis’ MS drug ofatumumab

FDA delays review of Novartis’ MS drug ofatumumab

Additional regulatory filings are currently underway and regulatory approval for ofatumumab in Europe is expected by the second quarter of next year, according to Novartis. ... Novartis paid $1bn for right to the drug from GlaxoSmithKline and Genmab in

Working together against COVID-19

Working together against COVID-19 A number of top pharma companies are included in the newly formed partnership, the COVID-19 Therapeutics Accelerator, including Eli Lilly, J&J, Merck, Novartis, Pfizer and Sanofi.

ASCO: Momentum gathers behind next wave of CAR-T therapies

ASCO: Momentum gathers behind next wave of CAR-T therapies Yescarta is already used to treat large B-cell lymphoma and – if approved for the new indication - would give the CAR-T a niche free of competition from Novartis’ rival CD19 ... If approved, the off-the-shelf CAR-T would be a rival to marketed

Pfizer’s Ibrance misses the mark in early breast cancer

Pfizer’s Ibrance misses the mark in early breast cancer Although Pfizer’s drug is the leader in this indication, it is facing increasing competition from the likes of Novartis’ Kisqali (ribociclib) and others for a share in the market.

Finalists 2020

for Novartis Pharmaceuticals UK Limited. Embracing Complexity: Towards New Approaches for Supporting People with Neurodevelopmental Conditions. ... Visualise Medical Education Programme. by Rock Unlimited. for Novartis. One Location, One Sanofi.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....